Efficacy of Daflon in the treatment of XXXX .

@entity1 @entity548 @entity11728 @entity111 @entity158 @entity6713
OBJECTIVE: To demonstrate the value of Daflon in the management of @entity6713 in Saudi @entity1 attending the Surgical clinic. METHODS: This is a prospective clinical study of 105 consecutive @entity1 suffering from @entity6713 including thrombosed piles. Detailed history and proctoscopic examination to determine position, size, and degree of @entity6713 was conducted in all @entity1 attending the Surgical Clinic at Dammam Central Hospital, Dammam, Kingdom of Saudi Arabia (KSA). The study was conducted over a 6-months period (December 2000 to May 2001). All were started on Daflon; 2 tablets twice daily for 4 weeks and were followed up weekly during the study period and proctoscopic examination was conducted at each consultation. RESULTS: The mean age was 35 (range 19-70) years. The majority (77%) suffered congested @entity6713 and only 8% had thrombosed piles. Previous surgery for piles was noted in 11%. Concomitant medical diseases were present in 10%. The degrees of piles were first degree (23 @entity1 ), 2nd degree (73), 3rd degree (9) and 4th degree (0). There was a statistically significant (p<0.001) improvement in @entity158 , @entity11728 , @entity548 , @entity111 , and mucosal discharge from baseline to last visit. There was also a significant (p<0.001) improvement on the proctoscopic appearance. Five @entity1 failed to improve on Daflon; therefore, they underwent surgery. The side effects of Daflon (mainly gastrointestinal symptoms) were encountered in 5 @entity1 but did not force interruption of the medication. CONCLUSION: Daflon is a very safe and effective drug in the treatment of all @entity6713 in the population of Eastern KSA.
